4-(1,1-Dioxothiomorpholino)benzaldehyde>98.0%(GC)5g

5-Nitrobenzo[d]oxazole-2(3H)-thione, 95.0%, 250mg

8-Nitro-3,4-dihydro-2H-benzo[b][1,4]dioxepin-7-amine, 95.0%, 10g

3-Chloro-tetrahydro-thiophene 1,1-dioxide, 95.0%, 250mg

Oxyde de tungstène(VI), min 99,5 %, pa, 500 g, emballage plastique.

4-Methyl-1,3-benzothiazole, 97%, 250mg

2-(4-Fluoro-phenylamino)-5-methyl-thiazole-4-carboxylic acid ethyl ester, 95.0%, 1g

6-Bromo-5-methoxypyridine-2-carboxylic acid, 97.0%, 5g

(2,4-Dihydroxyphenyl)(4-hydroxyphenyl)methanone, 97%, 5g

(S)-3-(N-BOC-N-METHYLAMINO)PYRROLIDINE HCL, 95.0%, 500mg

6,7-Dichloro-3,4-dihydronaphthalen-1(2H)-one, 97%, 1g

2-Thioxo-1,2-dihydropyridine-3-carboxamide, 98%, 10g

tert-butyl 2-phenyl-5-(pyrrolidin-1-ylcarbonyl)-5,7-dihydro-6H-pyrrolo[3,4-d]pyrimidine-6-carboxylate, 250mg